38
Beurer GL50
Concentration of
tested substances
50–100 mg/dL
(2.8–5.6 mmol/L)
250-350 mg/dL
(13.9-19.4 mmol/L)
L-Dopa
2 mg/dL
(0.10 mmol/L)
9.3 mg/dL
(0.52 mmol/L)
7.9%
Maltose
278 mg/dL
(7.72 mmol/L)
-1.53 mg/dL
(-0.09 mmol/L)
-2.6%
Methyldopa
4 mg/dL
(0.19 mmol/L)
7.3 mg/dL
(0.41 mmol/L)
0.9%
Pralidoxime iodide
5 mg/dL
(0.14 mmol/L)
1.7 mg/dL
(0.09 mmol/L)
-0.1%
Sodium salicylate
40 mg/dL
(2.50 mmol/L)
-3.1 mg/dL
(-0.17 mmol/L)
-0.6%
Salicylic acid
60 mg/dL
(4.34 mmol/L)
-0.1 mg/dL
(-0.01 mmol/L)
7.6%
Tolbutamide
100 mg/dL
(3.70 mmol/L)
0.5 mg/dL
(0.03 mmol/L)
-0.8%
Tolazamide
2.5 mg/dL
(0.08 mmol/L)
-2.3 mg/dL
(-0.13 mmol/L)
1.8%
Triglyceride
800 mg/dL
(9.37 mmol/L)
-7.50 mg/dL
(-0.42 mmol/L)
-4.0%
Uric acid
16.5 mg/dL
(0.98 mmol/L)
6.6 mg/dL
(0.37 mmol/L)
1.8%
Xylose
9.5 mg/dL
(0.63 mmol/L)
5.6 mg/dL
(0.31 mmol/L)
6.6%
12 w
arranty
and
customer
service
Beurer GmbH, Söflinger Straße 218, 89077 Ulm, Germany (hereinafter referred to as “Beurer”) provides
a warranty for this product, subject to the requirements below and to the extent described as follows.
The warranty conditions below shall not affect the seller’s statutory warranty obligations which
ensue from the sales agreement with the buyer.
The warranty shall apply without prejudice to any mandatory statutory provisions on liability.
Blood glucose
value
Influence
